Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Howard, Annie
Neill, Joanna C
Schlag, Anne Katrin
and
Lennox, Charlotte
2021.
Schedule 1 barriers to research in the UK: An in-depth qualitative analysis.
Drug Science, Policy and Law,
Vol. 7,
Issue. ,
Smausz, Rebecca
Neill, Joanna
and
Gigg, John
2022.
Neural mechanisms underlying psilocybin’s therapeutic potential – the need for preclinical in vivo electrophysiology.
Journal of Psychopharmacology,
Vol. 36,
Issue. 7,
p.
781.
Meyer-Lindenberg, Andreas
Dickson, Suzanne L.
Millan, Mark J.
and
Knudsen, Gitte M.
2022.
Prospects for improved prevention and treatment of neuropsychiatric disorders: Neuroscience Applied.
Neuroscience Applied,
Vol. 1,
Issue. ,
p.
100103.
Brandwein, Christiane
Leenaars, Cathalijn H.C.
Becker, Laura
Pfeiffer, Natascha
Iorgu, Ana-Maria
Hahn, Melissa
Vairani, Gaia A.
Lewejohann, Lars
Bleich, André
Mallien, Anne S.
and
Gass, Peter
2023.
A systematic mapping review of the evolution of the rat Forced Swim Test: Protocols and outcome parameters.
Pharmacological Research,
Vol. 196,
Issue. ,
p.
106917.
Kositsyn, Yuriy M.
de Abreu, Murilo S.
Kolesnikova, Tatiana O.
Lagunin, Alexey A.
Poroikov, Vladimir V.
Harutyunyan, Hasmik S.
Yenkoyan, Konstantin B.
and
Kalueff, Allan V.
2023.
Towards Novel Potential Molecular Targets for Antidepressant and Antipsychotic Pharmacotherapies.
International Journal of Molecular Sciences,
Vol. 24,
Issue. 11,
p.
9482.
Serretti, Alessandro
2023.
Innovation in psychopharmacology.
International Clinical Psychopharmacology,
Vol. 38,
Issue. 5,
p.
281.
Zhang, Jing-Yi
Wang, Ya-Tao
Sun, Lu
Wang, Sai-Qi
and
Chen, Zhe-Sheng
2023.
Synthesis and clinical application of new drugs approved by FDA in 2022.
Molecular Biomedicine,
Vol. 4,
Issue. 1,
Pan, Jin
Lu, Yanting
Wang, Sijia
Ma, Ting
Xue, Xiaoyan
Zhang, Zhe
Mao, Qiancheng
Guo, Dongjing
and
Ma, Ke
2023.
Synergistic neuroprotective effects of two natural medicinal plants against CORT-induced nerve cell injury by correcting neurotransmitter deficits and inflammation imbalance.
Phytomedicine,
Vol. 121,
Issue. ,
p.
155102.
Oliveira-Maia, Albino J.
Rive, Benoit
Morrens, Joachim
Godinov, Yordan
Cabrieto, Jedelyn
Perualila, Nolen
and
Mulhern-Haughey, Siobhán
2023.
Indirect adjusted comparison of 6-month clinical outcomes between esketamine nasal spray and other real-world polypharmacy treatment strategies for treatment resistant depression: results from the ICEBERG study.
Frontiers in Psychiatry,
Vol. 14,
Issue. ,
Di Bartolomeo, Luca
Custurone, Paolo
Irrera, Natasha
Borgia, Francesco
Vaccaro, Federico
Squadrito, Francesco
and
Vaccaro, Mario
2023.
Vitiligo and Mental Health: Natural Compounds’ Usefulness.
Antioxidants,
Vol. 12,
Issue. 1,
p.
176.
Gong, Guowei
Ganesan, Kumar
Wan, Yukai
Liu, Yaqun
Huang, Yongping
Luo, Yuting
Wang, Xuexu
Zhang, Zhenxia
and
Zheng, Yuzhong
2024.
Unveiling the neuroprotective properties of isoflavones: current evidence, molecular mechanisms and future perspectives.
Critical Reviews in Food Science and Nutrition,
p.
1.
Olivier, Berend
and
Olivier, Jocelien D. A.
2024.
Recent Advances and Challenges in the Treatment of Major Depressive Disorder.
Vol. 1456,
Issue. ,
p.
49.
Nicosia, Noemi
Giovenzana, Mattia
Misztak, Paulina
Mingardi, Jessica
and
Musazzi, Laura
2024.
Glutamate-Mediated Excitotoxicity in the Pathogenesis and Treatment of Neurodevelopmental and Adult Mental Disorders.
International Journal of Molecular Sciences,
Vol. 25,
Issue. 12,
p.
6521.
Liu, Yike
Dai, Chenlin
Wang, Chendi
Wang, Jiayao
Yan, Weikang
Luo, Maowen
Dong, Juane
Li, Xiulian
Liu, Xuebo
and
Lan, Ying
2024.
Raspberry Ketone Prevents LPS‐Induced Depression‐Like Behaviors in Mice by Inhibiting TLR‐4/NF‐κB Signaling Pathway via the Gut‐Brain Axis.
Molecular Nutrition & Food Research,
Vol. 68,
Issue. 11,
Pan, Xingli
Gao, Yuxin
Guan, Kaifu
Chen, Jing
and
Ji, Bingyuan
2024.
Ghrelin/GHSR System in Depressive Disorder: Pathologic Roles and Therapeutic Implications.
Current Issues in Molecular Biology,
Vol. 46,
Issue. 7,
p.
7324.
Sharma, Aditya
Alam, Md. Aftab
Kaur, Awaneet
Sharma, Shaweta
and
Yadav, Shikha
2024.
Psychopharmacological Treatment of Depression and Anxiety and
their Different Drug Delivery Targets.
Current Psychiatry Research and Reviews,
Vol. 20,
Issue. 4,
p.
297.
Greydanus, Donald E.
Nazeer, Ahsan
Qayyum, Zheala
Patel, Dilip R.
Rausch, Rebecca
Hoang, Linh-Nhu
Miller, Caroline
Chahin, Summer
Apple, Roger W.
Saha, Gautam
Prasad Rao, G.
and
Javed, Afzal
2024.
Pediatric suicide: Review of a preventable tragedy.
Disease-a-Month,
Vol. 70,
Issue. 9,
p.
101725.
Iqbal, Syed Z.
Saxena, Kirti
Lateef, Amir
Khan, Samiyah
Blassingame, Jonathan
and
Shah, Asim A.
2024.
Treatment-Resistant Depression and Medications.
Psychiatric Annals,
Vol. 54,
Issue. 6,
Kurkin, D.V.
Morkovin, E.I.
Bakulin, D.A.
Gorbunova, Yu.V.
Ivanova, O.V.
Pavlova, E.V.
Zvereva, V.I.
Dzhavakhyan, M.A.
Krysanov, I.S.
Kolosov, Yu.A.
Zaborovsky, A.V.
Strygin, A.V.
Petrov, V.I.
Beliy, P.A.
Zaslavskaya, K.Y.
Maltsev, D.V.
and
Skripka, M.O.
2024.
Targeting NMDAR/AMPAR: a promising pharmacotherapeutic approach for depressive disorders.
S.S. Korsakov Journal of Neurology and Psychiatry,
Vol. 124,
Issue. 5,
p.
22.
Duan, Wenwen
Cao, Dongmei
Wang, Sheng
and
Cheng, Jianjun
2024.
Serotonin 2A Receptor (5-HT2AR) Agonists: Psychedelics and Non-Hallucinogenic Analogues as Emerging Antidepressants.
Chemical Reviews,
Vol. 124,
Issue. 1,
p.
124.